Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
- PMID: 36701677
- PMCID: PMC10161746
- DOI: 10.1164/rccm.202209-1795CI
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice
Abstract
Patients with chronic obstructive pulmonary disease (COPD) may suffer from acute episodes of worsening dyspnea, often associated with increased cough, sputum, and/or sputum purulence. These exacerbations of COPD (ECOPDs) impact health status, accelerate lung function decline, and increase the risk of hospitalization. Importantly, close to 20% of patients are readmitted within 30 days after hospital discharge, with great cost to the person and society. Approximately 25% and 65% of patients hospitalized for an ECOPD die within 1 and 5 years, respectively. Patients with COPD are usually older and frequently have concomitant chronic diseases, including heart failure, coronary artery disease, arrhythmias, interstitial lung diseases, bronchiectasis, asthma, anxiety, and depression, and are also at increased risk of developing pneumonia, pulmonary embolism, and pneumothorax. All of these morbidities not only increase the risk of subsequent ECOPDs but can also mimic or aggravate them. Importantly, close to 70% of readmissions after an ECOPD hospitalization result from decompensation of other morbidities. These observations suggest that in patients with COPD with worsening dyspnea but without the other classic characteristics of ECOPD, a careful search for these morbidities can help detect them and allow appropriate treatment. For most morbidities, a thorough clinical evaluation supplemented by appropriate clinical investigations can guide the healthcare provider to make a precise diagnosis. This perspective integrates the currently dispersed information available and provides a practical approach to patients with COPD complaining of worsening respiratory symptoms, particularly dyspnea. A systematic approach should help improve outcomes and the personal and societal cost of ECOPDs.
Keywords: COPD; algorithms; differential diagnosis; symptom flare-up.
Figures





Similar articles
-
[Guidelines for the prevention and management of bronchial asthma (2024 edition)].Zhonghua Jie He He Hu Xi Za Zhi. 2025 Mar 12;48(3):208-248. doi: 10.3760/cma.j.cn112147-20241013-00601. Zhonghua Jie He He Hu Xi Za Zhi. 2025. PMID: 40050074 Chinese.
-
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2. Cochrane Database Syst Rev. 2021. PMID: 34693988 Free PMC article.
-
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2. Cochrane Database Syst Rev. 2017. PMID: 28777450 Free PMC article.
-
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558. Health Technol Assess. 2025. PMID: 40418146 Clinical Trial.
-
Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360. Health Technol Assess. 2015. PMID: 25980984 Free PMC article.
Cited by
-
[Epidemiology and hospitalization costs analysis of female inpatients with acute exacerbation of chronic obstructive pulmonary disease in Beijing from 2013 to 2020].Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Dec 18;55(6):1074-1081. doi: 10.19723/j.issn.1671-167X.2023.06.019. Beijing Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 38101792 Free PMC article. Chinese.
-
Detrimental Impact of Atrial Fibrillation among Patients Hospitalized for Acute Exacerbation of COPD: Results of a Population-Based Study in Spain from 2016 to 2021.J Clin Med. 2024 May 9;13(10):2803. doi: 10.3390/jcm13102803. J Clin Med. 2024. PMID: 38792346 Free PMC article.
-
Interplay between Lung Diseases and Viral Infections: A Comprehensive Review.Microorganisms. 2024 Oct 8;12(10):2030. doi: 10.3390/microorganisms12102030. Microorganisms. 2024. PMID: 39458339 Free PMC article. Review.
-
Hyperkalemia Is an Underestimated Risk Factor in COPD.Int J Chron Obstruct Pulmon Dis. 2025 Mar 15;20:723-734. doi: 10.2147/COPD.S490620. eCollection 2025. Int J Chron Obstruct Pulmon Dis. 2025. PMID: 40110488 Free PMC article.
-
Clinical analysis of the correlation between nutritional risk screening and prognosis of patients with chronic obstructive pulmonary disease.Pak J Med Sci. 2025 Feb;41(2):608-613. doi: 10.12669/pjms.41.2.9566. Pak J Med Sci. 2025. PMID: 39926681 Free PMC article.
References
-
- Global Initiative for Chronic Obstructive Lung Disease. 2023. https://goldcopd.org/2023-gold-report-2/
-
- Riley CM, Sciurba FC. Diagnosis and outpatient management of chronic obstructive pulmonary disease: a review. JAMA . 2019;321:786–797. - PubMed
-
- Celli BR, Wedzicha JA. Update on clinical aspects of chronic obstructive pulmonary disease. N Engl J Med . 2019;381:1257–1266. - PubMed
-
- Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, et al. BODE Collaborative Group Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med . 2012;186:155–161. - PubMed
-
- MacLeod M, Papi A, Contoli M, Beghé B, Celli BR, Wedzicha JA, et al. Chronic obstructive pulmonary disease exacerbation fundamentals: diagnosis, treatment, prevention and disease impact. Respirology . 2021;26:532–551. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical